Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training in Elderly With Mild and Moderate Cognitive Impairment

August 30, 2026 updated by: Fouzia Batool, Shifa Tameer-e-Millat University

Immediate Versus Progressive-Standing Dual-Task Training: A Comparative Evaluation in Elderly With Mild and Moderate Cognitive Impairment

older adults with mild and moderate cognitive impairment. compare immediate vs progressive standing dual-task training. assess balance, cognition, executive function, mobility, and quality of life.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Capital
      • Islamabad, Capital, Pakistan
        • Recruiting
        • Pakistan Institute of Medical Sciences
        • Contact:
        • Principal Investigator:
          • Erica Arthur, DPT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥55 years
  • Mild or moderate cognitive impairment
  • MoCA 10-25
  • MMSE 10-23
  • Able to participate
  • Provides informed consent

Exclusion Criteria:

  • Severe cognitive impairment
  • Severe sensory or musculoskeletal impairments
  • Unstable medical conditions
  • Participation in another intervention study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Immediate Standing Dual-Task Training (Mild Cognitive Impairment)

Motor-cognitive dual-task training is a rehabilitation intervention delivered by a physiotherapist over 8 weeks, with three sessions per week, each lasting 45 minutes. Every session consists of a 5-minute warm-up, 30-35 minutes of dual-task training, and a 5-minute cool-down.

It simultaneously combines motor and cognitive tasks. Motor components include marching in place, finger tapping, hand transfer activities, side stepping, weight shifting, heel raises, heel-toe stepping, and balance challenges. Cognitive components include naming animals or fruits, counting forward, and months, serial subtraction by threes, backward digit span, alternate naming, and word recall.

Participants allocated to the Immediate Standing intervention perform all dual-task activities in standing from the first treatment session.

Other Names:
  • progressive standing dual task training
Experimental: Progressive Standing Dual-Task Training (Mild Cognitive Impairment)

Motor-cognitive dual-task training is a rehabilitation intervention delivered by a physiotherapist over 8 weeks, with three sessions per week, each lasting 45 minutes. Every session consists of a 5-minute warm-up, 30-35 minutes of dual-task training, and a 5-minute cool-down.

It simultaneously combines motor and cognitive tasks. Motor components include marching in place, finger tapping, hand transfer activities, side stepping, weight shifting, heel raises, heel-toe stepping, and balance challenges. Cognitive components include naming animals or fruits, counting forward, and months, serial subtraction by threes, backward digit span, alternate naming, and word recall.

Participants allocated to the Progressive Standing intervention initially perform dual-task activities sitting and progressively transition to standing during the intervention period.

Experimental: Immediate Standing Dual-Task Training (Moderate Cognitive Impairment)

Motor-cognitive dual-task training is a rehabilitation intervention delivered by a physiotherapist over 8 weeks, with three sessions per week, each lasting 45 minutes. Every session consists of a 5-minute warm-up, 30-35 minutes of dual-task training, and a 5-minute cool-down.

It simultaneously combines motor and cognitive tasks. Motor components include marching in place, finger tapping, hand transfer activities, side stepping, weight shifting, heel raises, heel-toe stepping, and balance challenges. Cognitive components include naming animals or fruits, counting forward, and months, serial subtraction by threes, backward digit span, alternate naming, and word recall.

Participants allocated to the Immediate Standing intervention perform all dual-task activities in standing from the first treatment session.

Other Names:
  • progressive standing dual task training
Experimental: Progressive Standing Dual-Task Training (Moderate Cognitive Impairment)

Motor-cognitive dual-task training is a rehabilitation intervention delivered by a physiotherapist over 8 weeks, with three sessions per week, each lasting 45 minutes. Every session consists of a 5-minute warm-up, 30-35 minutes of dual-task training, and a 5-minute cool-down.

It simultaneously combines motor and cognitive tasks. Motor components include marching in place, finger tapping, hand transfer activities, side stepping, weight shifting, heel raises, heel-toe stepping, and balance challenges. Cognitive components include naming animals or fruits, counting forward, and months, serial subtraction by threes, backward digit span, alternate naming, and word recall.

Participants allocated to the Progressive Standing intervention initially perform dual-task activities sitting and progressively transition to standing during the intervention period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mini-Mental State Examination
Time Frame: Baseline and Week 8
The Mini-Mental State Examination (MMSE) is a 30-point measure of global cognitive function. Scores range from 0 to 30, with higher scores indicating better cognitive function
Baseline and Week 8
Berg Balance Scale
Time Frame: Baseline and Week 8
The Berg Balance Scale (BBS) is a 14-item clinical measure of static and dynamic balance. Total scores range from 0 to 56, with higher scores indicating better balance performance.
Baseline and Week 8
Timed Up and Go
Time Frame: Baseline and Week 8
The Timed Up and Go Test measures functional mobility. The outcome is the time (seconds) required to stand from a chair, walk 3 meters, turn, return, and sit. Lower completion times indicate better mobility.
Baseline and Week 8
Trail Making Test
Time Frame: Baseline and Week 8
The Trail Making Test Part assesses executive function and cognitive flexibility. The outcome is the time (seconds) required to complete the test. Lower completion times indicate better executive function.
Baseline and Week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life in Alzhiemer's Disease Scale
Time Frame: Baseline and Week 8
The Quality of Life in Alzheimer's Disease (QoL-AD) questionnaire consists of 13 items, with total scores ranging from 13 to 52. Higher scores indicate better quality of life.
Baseline and Week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 25, 2026

Primary Completion (Estimated)

August 25, 2026

Study Completion (Estimated)

August 30, 2026

Study Registration Dates

First Submitted

August 9, 2026

First Submitted That Met QC Criteria

August 9, 2026

First Posted (Actual)

August 13, 2026

Study Record Updates

Last Update Posted (Actual)

September 1, 2026

Last Update Submitted That Met QC Criteria

August 30, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 099-26

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe